Pharmaceuticals

Lowering the bar to purity claims

Every so often, the European Patent Office issues a decision on a case which has important consequences for other patent applicants. The recent decision T1085/13 (discussed in greater detail here) has implications for how purity claims are assessed at the EPO and may be seen as patentee-friendly, particularly for the...

Read more

AI Accelerates Innovation

This article was originally posted on Communications of the ACM and remains their copyrighted material. Please visit their website here to read the full article. “To invent, you need a good imagination and a pile of junk.” So said Thomas Edison, America’s most prolific inventor. Yet the march of technology is now changing...

Read more

A Right Pain in the Peripheries? The Supreme Court Decision in Warner-Lambert v Generics & Actavis

Summary In a significant judgment, the UK Supreme Court has rejected Warner-Lambert’s appeal against the revocation of patent EP(UK) No. 0934061, for the use of pregabalin in the treatment of pain. A key part of the ruling was the upholding of the appeal decision that a higher threshold of plausibility...

Read more

Wisdom of the crowd: how to make sure IP doesn’t derail your crowdfunding efforts

Startups raising hundreds of thousands – even millions – of pounds via Kickstarter may be rarer than it once was, but crowdfunding remains a popular method of fundraising. There are a myriad of options, whether you go down the equity crowdfunding route offered by the likes of Seedrs, CrowdCube, and...

Read more

AI-generated in silico data in patent applications

The impact of AI-generated in silico data on pharma patent applications In silico data generated using AI platforms can identify existing medication candidates and match them with diseases and conditions that do not yet have a cure much quicker and more reliably than a human will ever be able to do. However, it...

Read more